Pathway Diagnostics: Biomarker Development, Testing and Commercialization Ask Us How

What's New

QUEST DIAGNOSTICS ACQUIRES PATHWAY DIAGNOSTICS TO EXPAND BIOMARKER AND ONCOLOGY TESTING

December 9, 2008
Click here for news story.

May 7, 2008
Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop™ II Molecular HIV Co-receptor Tropism Assay

December 28, 2007
Pathway Diagnostics’ SensiTrop Assay Update

November 15, 2007
Pathway Diagnostics Announces Patent issuance for the diagnostic measurement of HIV tropism for the initiation or modification of HIV therapy

October 27, 2007
Quest Diagnostics Licenses Pathway's SensiTrop™ Assay

October 3, 2007
Pathway Diagnostics Announces Commercial Availability of SensiTrop™ HIV Co-receptor Tropism Assay

Learn more about SensiTrop™ and HIV Tropism.

 

What's New "Announcing SensiTrop™ II HIV co-receptor tropism assay, combining the sensitivity of heteroduplex tracking and the specificity of DNA sequence analysis "
©2009 Quest Diagnostics. Privacy Policy.